Quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccine (KWA-drih-VA-lent HYOO-mun PA-pih-LOH-muh-VY-rus … ree-KOM-bih-nunt V

A vaccine used to prevent cervical, vulvar, and vaginal cancer caused by human papillomavirus (HPV) types 16 and 18 and genital warts caused by HPV types 6 and 11. It is also used to prevent lesions that are caused by these viruses and that can lead to cervical, vulvar, or vaginal cancer. Quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccine is used in females aged 9-26 years. It is also used to prevent genital warts in males aged 9-26 years. Quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccine is being studied in the treatment of other medical conditions. Also called Gardasil.